Currently Enrolling
Trial Physician / Study Coordinator
Tiffany Herndon
Email Phone (801) 747-9186Site Name
Utah Kidney Research Institute
3702 S State St, Ste 107, Salt Lake City, UT 84115
Find other locations for this trial:
Currently Enrolling
Eligibility Criteria
About the Drug
What is involved for the patient
Target Enrollment
Up to 125 patients FSGS / TR-MCD or DN are planned to be enrolled into the study.
Estimated End Date
TBC